Eurocept, an Ankeveen, the Netherlands-based healthcare company, received a minority investment of undisclosed amount.
Gimv and the Gimv Health & Care Fund made the investment, which will be subject to the necessary approval of the Dutch competition authority.
The company intends to use the funds to further strengthen its position in the Netherlands and expand to neighbouring countries through organic growth and strategic takeovers.
Founded in 2001 by CEO Mike van Woensel, Eurocept sells specialized medicines and provides medical homecare services. Eurocept Pharmaceuticals is responsible for the registration, marketing, distribution and sale of speciality medicines in the fields of anesthetics, psychiatry, urology, pediatrics and infectious diseases. Eurocept Homecare provides medical specialist homecare and related out-patient medical technology for medicine and food administration.
The group had a turnover of €147m in 2012 and more than 130 employees working in the Benelux and the rest of Europe.